176 related articles for article (PubMed ID: 16960405)
1. Re-elevation of high-sensitivity C-reactive protein but not the von Willebrand Factor after withdrawing atorvastatin therapy in patients with unstable angina undergoing coronary artery stenting.
Yip HK; Youssef AA; Chua S; Hung WC; Chen YH; Yeh KH; Wu CJ; Hang CL
Int Heart J; 2006 Jul; 47(4):501-9. PubMed ID: 16960405
[TBL] [Abstract][Full Text] [Related]
2. High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina.
Chyrchel M; Dudek D; Bartuś S; Legutko J; Heba G; Dubiel JS
Kardiol Pol; 2004 Sep; 61(9):213-21; discussion 222-4. PubMed ID: 15531933
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of high-sensitivity C-reactive protein predict progressively obstructive lesions rather than late restenosis in patients with unstable angina undergoing coronary artery stenting.
Yip HK; Hung WC; Yang CH; Chen YH; Cheng CI; Chen SM; Yeh KH
Circ J; 2005 Oct; 69(10):1202-7. PubMed ID: 16195617
[TBL] [Abstract][Full Text] [Related]
4. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
Nidorf M; Thompson PL
Am J Cardiol; 2007 Mar; 99(6):805-7. PubMed ID: 17350370
[TBL] [Abstract][Full Text] [Related]
5. Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension.
Konduracka E; Galicka-Latala D; Cieslik G; Rostoff P; Fedak D; Sieradzki J; Naskalski J; Piwowarska W
Diabetes Obes Metab; 2008 Sep; 10(9):719-25. PubMed ID: 17941871
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction.
Correia LC; Spósito AC; Lima JC; Magalhães LP; Passos LC; Rocha MS; D'Oliveira A; Esteves JP
Am J Cardiol; 2003 Aug; 92(3):298-301. PubMed ID: 12888137
[TBL] [Abstract][Full Text] [Related]
7. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.
Tousoulis D; Bosinakou E; Kotsopoulou M; Antoniades C; Katsi V; Stefanadis C
Int J Cardiol; 2006 Jan; 106(3):333-7. PubMed ID: 16337041
[TBL] [Abstract][Full Text] [Related]
8. Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting.
Yip HK; Wu CJ; Yang CH; Chang HW; Fang CY; Hung WC; Hang CL
Circ J; 2005 Aug; 69(8):890-5. PubMed ID: 16041155
[TBL] [Abstract][Full Text] [Related]
9. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
Bonnet J; McPherson R; Tedgui A; Simoneau D; Nozza A; Martineau P; Davignon J;
Clin Ther; 2008 Dec; 30(12):2298-313. PubMed ID: 19167589
[TBL] [Abstract][Full Text] [Related]
11. Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.
Schaefer EJ; McNamara JR; Asztalos BF; Tayler T; Daly JA; Gleason JL; Seman LJ; Ferrari A; Rubenstein JJ
Am J Cardiol; 2005 May; 95(9):1025-32. PubMed ID: 15842965
[TBL] [Abstract][Full Text] [Related]
12. [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin].
Su JZ; Xue Y; Cai WQ; Huang QY; Chai DJ; Chen GL; Wang FB; Chen XP; Zhang DS
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Sep; 39(9):807-11. PubMed ID: 22321227
[TBL] [Abstract][Full Text] [Related]
13. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
Ray KK; Cannon CP; Cairns R; Morrow DA; Rifai N; Kirtane AJ; McCabe CH; Skene AM; Gibson CM; Ridker PM; Braunwald E;
J Am Coll Cardiol; 2005 Oct; 46(8):1417-24. PubMed ID: 16226164
[TBL] [Abstract][Full Text] [Related]
14. [Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial].
Namal E; Sener N; Ulaş T; Akçalı Z; Oztekin E; Borlu F
Anadolu Kardiyol Derg; 2011 Dec; 11(8):703-10. PubMed ID: 22088858
[TBL] [Abstract][Full Text] [Related]
15. [Immunoinflammatory factors in unstable angina. Possibility of influence of atorvastatin].
Logacheva IV; Kazantseva MO
Kardiologiia; 2007; 47(6):15-20. PubMed ID: 18260869
[TBL] [Abstract][Full Text] [Related]
16. Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity.
Chan DC; Watts GF; Barrett PH; Beilin LJ; Mori TA
Clin Chem; 2002 Jun; 48(6 Pt 1):877-83. PubMed ID: 12029003
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy.
Miedema MD; Conover CA; MacDonald H; Harrington SC; Oberg D; Wilson D; Henry TD; Schwartz RS
Am J Cardiol; 2008 Jan; 101(1):35-9. PubMed ID: 18157962
[TBL] [Abstract][Full Text] [Related]
18. Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment.
Baldassarre D; Porta B; Camera M; Amato M; Arquati M; Brusoni B; Fiorentini C; Montorsi P; Romano S; Veglia F; Tremoli E; Cortellaro M;
Nutr Metab Cardiovasc Dis; 2009 Sep; 19(7):481-90. PubMed ID: 19171469
[TBL] [Abstract][Full Text] [Related]
19. Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation.
Liu M; Wang F; Wang Y; Jin R
Cardiovasc Drugs Ther; 2009 Oct; 23(5):369-76. PubMed ID: 19636689
[TBL] [Abstract][Full Text] [Related]
20. Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy.
van Wissen S; Trip MD; Smilde TJ; de Graaf J; Stalenhoef AF; Kastelein JJ
Atherosclerosis; 2002 Dec; 165(2):361-6. PubMed ID: 12417288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
